🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 129 (from laksa016)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa129.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://pubmed.ncbi.nlm.nih.gov/28885920/\')), getAhrefsUnparsedNoserviceFromURL(\'https://pubmed.ncbi.nlm.nih.gov/28885920/\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/28885920\/","crawl_time":1749782588,"first_indexed_time":1584431460,"http_code":200,"src_unparsed":"gov,nih!nlm,ncbi,pubmed,\/28885920\/ s443","src_root_hash":"7295144728021232729","history_drop_reason":"tooold","meta_title":"Antibiotic Therapy for Acute Watery Diarrhea and Dysentery","meta_descriptions":["Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces sympto …"],"attrs_boilerpipe_text":"\n      \n      Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness. Presently, azithromycin is the preferred first-line antibiotic for the treatment of acute watery diarrhea (single dose 500 mg), as well as for febrile diarrhea and dysentery (single dose 1,000 mg). Levofloxacin and ciprofloxacin are also options for acute watery diarrhea (single dose 500 mg and 750 mg, respectively) and febrile diarrhea\/dysentery in areas with high rates of Shigella (500 mg once for 3 days [once daily with levofloxacin and twice daily with ciprofloxacin]), but are becoming less effective because of increasing fluoroquinolone resistance, particularly among Campylobacter spp. Another alternate for acute watery diarrhea is rifaximin (200 mg 3 times per day for 3 days); however, it should not be used with invasive illness. Use of loperamide in combination with antibiotic treatment is also beneficial as it has been shown to further reduce gastrointestinal symptoms and duration of illness. Because of regional differences in the predominance of pathogens and resistance levels, choice of antibiotic should take travel destination into consideration.\n    ","attrs_markdown":"# Antibiotic Therapy for Acute Watery Diarrhea and Dysentery\nMil Med. 2017 Sep;182(S2):17-25.   doi: 10.7205\/MILMED-D-17-00068.\n\n### Author\n[David R Tribble](https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Tribble+DR&cauthor_id=28885920)  [1](https:\/\/pubmed.ncbi.nlm.nih.gov\/28885920\/#affiliation-1 \"Infectious Disease Clinical Research Program, Preventive Medicine and Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.\")\n\n### Affiliation\n- 1 Infectious Disease Clinical Research Program, Preventive Medicine and Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.\n\n- PMID:   [28885920](https:\/\/pubmed.ncbi.nlm.nih.gov\/28885920\/)\n- PMCID:   [PMC5650106](https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5650106\/)\n- DOI:   [10\\.7205\/MILMED-D-17-00068](https:\/\/doi.org\/10.7205\/milmed-d-17-00068)\n\n## Abstract\nDiarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness. Presently, azithromycin is the preferred first-line antibiotic for the treatment of acute watery diarrhea (single dose 500 mg), as well as for febrile diarrhea and dysentery (single dose 1,000 mg). Levofloxacin and ciprofloxacin are also options for acute watery diarrhea (single dose 500 mg and 750 mg, respectively) and febrile diarrhea\/dysentery in areas with high rates of Shigella (500 mg once for 3 days \\[once daily with levofloxacin and twice daily with ciprofloxacin\\]), but are becoming less effective because of increasing fluoroquinolone resistance, particularly among Campylobacter spp. Another alternate for acute watery diarrhea is rifaximin (200 mg 3 times per day for 3 days); however, it should not be used with invasive illness. Use of loperamide in combination with antibiotic treatment is also beneficial as it has been shown to further reduce gastrointestinal symptoms and duration of illness. Because of regional differences in the predominance of pathogens and resistance levels, choice of antibiotic should take travel destination into consideration.\n\nReprint & Copyright © 2017 Association of Military Surgeons of the U.S.\n\n## MeSH terms\n- Anti-Bacterial Agents \/ therapeutic use\\*\n- Azithromycin \/ therapeutic use\n- Ciprofloxacin \/ therapeutic use\n- Developing Countries \/ statistics & numerical data\n- Diarrhea \/ drug therapy\\*\n- Diarrhea \/ etiology\n- Dysentery \/ drug therapy\\*\n- Humans\n- Levofloxacin \/ therapeutic use\n- Military Personnel \/ statistics & numerical data\n- Rifamycins \/ therapeutic use\n- Rifaximin\n\n## Substances\n- Anti-Bacterial Agents\n- Rifamycins\n- Ciprofloxacin\n- Levofloxacin\n- Azithromycin\n- Rifaximin\n\n## Grants and funding\n- [Y01 AI005072\/AI\/NIAID NIH HHS\/United States](https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Y01+AI005072%2FAI%2FNIAID+NIH+HHS%2FUnited+States%5BGrants+and+Funding%5D&sort=date&sort_order=desc \"All articles for grant Y01 AI005072\/AI\/NIAID NIH HHS\/United States\")","attrs_readable_markdown":null,"meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

🚫

NOT INDEXABLE

✅

CRAWLED

10 months ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	FAIL	`download_stamp > now() - 6 MONTH`	10.1 months ago
History drop	FAIL	`isNull(history_drop_reason)`	tooold
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://pubmed.ncbi.nlm.nih.gov/28885920/
Last Crawled	2025-06-13 02:43:08 (10 months ago)
First Indexed	2020-03-17 07:51:00 (6 years ago)
HTTP Status Code	200
Meta Title	Antibiotic Therapy for Acute Watery Diarrhea and Dysentery
Meta Description	Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces sympto …
Meta Canonical	null
Boilerpipe Text	Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness. Presently, azithromycin is the preferred first-line antibiotic for the treatment of acute watery diarrhea (single dose 500 mg), as well as for febrile diarrhea and dysentery (single dose 1,000 mg). Levofloxacin and ciprofloxacin are also options for acute watery diarrhea (single dose 500 mg and 750 mg, respectively) and febrile diarrhea/dysentery in areas with high rates of Shigella (500 mg once for 3 days [once daily with levofloxacin and twice daily with ciprofloxacin]), but are becoming less effective because of increasing fluoroquinolone resistance, particularly among Campylobacter spp. Another alternate for acute watery diarrhea is rifaximin (200 mg 3 times per day for 3 days); however, it should not be used with invasive illness. Use of loperamide in combination with antibiotic treatment is also beneficial as it has been shown to further reduce gastrointestinal symptoms and duration of illness. Because of regional differences in the predominance of pathogens and resistance levels, choice of antibiotic should take travel destination into consideration.
Markdown	# Antibiotic Therapy for Acute Watery Diarrhea and Dysentery Mil Med. 2017 Sep;182(S2):17-25. doi: 10.7205/MILMED-D-17-00068. ### Author [David R Tribble](https://pubmed.ncbi.nlm.nih.gov/?term=Tribble+DR&cauthor_id=28885920) [1](https://pubmed.ncbi.nlm.nih.gov/28885920/#affiliation-1 "Infectious Disease Clinical Research Program, Preventive Medicine and Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.") ### Affiliation - 1 Infectious Disease Clinical Research Program, Preventive Medicine and Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814. - PMID: [28885920](https://pubmed.ncbi.nlm.nih.gov/28885920/) - PMCID: [PMC5650106](https://pmc.ncbi.nlm.nih.gov/articles/PMC5650106/) - DOI: [10\.7205/MILMED-D-17-00068](https://doi.org/10.7205/milmed-d-17-00068) ## Abstract Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness. Presently, azithromycin is the preferred first-line antibiotic for the treatment of acute watery diarrhea (single dose 500 mg), as well as for febrile diarrhea and dysentery (single dose 1,000 mg). Levofloxacin and ciprofloxacin are also options for acute watery diarrhea (single dose 500 mg and 750 mg, respectively) and febrile diarrhea/dysentery in areas with high rates of Shigella (500 mg once for 3 days \[once daily with levofloxacin and twice daily with ciprofloxacin\]), but are becoming less effective because of increasing fluoroquinolone resistance, particularly among Campylobacter spp. Another alternate for acute watery diarrhea is rifaximin (200 mg 3 times per day for 3 days); however, it should not be used with invasive illness. Use of loperamide in combination with antibiotic treatment is also beneficial as it has been shown to further reduce gastrointestinal symptoms and duration of illness. Because of regional differences in the predominance of pathogens and resistance levels, choice of antibiotic should take travel destination into consideration. Reprint & Copyright © 2017 Association of Military Surgeons of the U.S. ## MeSH terms - Anti-Bacterial Agents / therapeutic use\* - Azithromycin / therapeutic use - Ciprofloxacin / therapeutic use - Developing Countries / statistics & numerical data - Diarrhea / drug therapy\* - Diarrhea / etiology - Dysentery / drug therapy\* - Humans - Levofloxacin / therapeutic use - Military Personnel / statistics & numerical data - Rifamycins / therapeutic use - Rifaximin ## Substances - Anti-Bacterial Agents - Rifamycins - Ciprofloxacin - Levofloxacin - Azithromycin - Rifaximin ## Grants and funding - [Y01 AI005072/AI/NIAID NIH HHS/United States](https://pubmed.ncbi.nlm.nih.gov/?term=Y01+AI005072%2FAI%2FNIAID+NIH+HHS%2FUnited+States%5BGrants+and+Funding%5D&sort=date&sort_order=desc "All articles for grant Y01 AI005072/AI/NIAID NIH HHS/United States")
Readable Markdown	null
Shard	129 (laksa)
Root Hash	7295144728021232729
Unparsed URL	gov,nih!nlm,ncbi,pubmed,/28885920/ s443